Kenvue (KVUE) Announces Closing of IPO
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/26/2026
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Stock action shows confidence in central banks: BofA’s Hartnett
- Oil prices slide about 2% as US, Iran explore path out of war
- Why stocks held up despite rising yields and $100 oil? These 2 words explain it
- Barclays asks if equity markets are nearing the boiling point
- White House blocks CNN from Air Force One trip, Washington Post reports
- Merck and Daiichi Sankyo withdraw lung cancer drug application
- Exclusive-SK Hynix's Solidigm weighs IPO that could value the unit at up to $150 billion, sources say
- Wall Street ends higher as investors buy AI stocks; Microsoft rallies
- Fox Factory sells Marucci Sports for $225M, cuts debt
Kenvue Announces Closing of Initial Public Offering
May 8, 2023 4:33 PM EDTSKILLMAN, N.J.--(BUSINESS WIRE)-- Kenvue Inc. (NYSE: KVUE) (Kenvue) the worlds largest pure-play consumer health company by revenue, today announced the closing of its initial public offering (IPO) of 198,734,444 shares of its common stock at a price to the public of $22.00 per share, including the underwriters full exercise of their option to purchase 25,921,884 shares to cover over-allotments. Shares of Kenvues common stock began trading on the New York Stock Exchange under the symbol KVUE on May 4, 2023.
As of the closing of the IPO, Johnson & Johnson (NYSE: JNJ)... More
